Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Brain Research

• Publication date

  2016-12-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.brainres.2016.09.038PMID 27693413
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuronal Nitric Oxide Synthase

  2017cited by this paper
• Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society

  2016cited by this paper
• Immunity and Inflammation in Epilepsy.

  2016cited by this paper
• The anti-ictogenic effects of levetiracetam are mirrored by interictal spiking and high-frequency oscillation changes in a model of temporal lobe epilepsy.

  2015cited by this paper
• Angiopoietin‐2: a multifaceted cytokine that functions in both angiogenesis and inflammation

  2015cited by this paper
• Evidence-based guideline: Management of an unprovoked first seizure in adults

  2015cited by this paper
• Prevention of status epilepticus-induced brain edema and neuronal cell loss by repeated treatment with high-dose levetiracetam.

  2015cited by this paper
• Inflammation induced at different developmental stages affects differently the range of microglial reactivity and the course of seizures evoked in the adult rat.

  2015cited by this paper
• Dual Role of Superoxide Dismutase 2 Induced in Activated Microglia

  2015cited by this paper
• Inflammatory pathways of seizure disorders.

  2014cited by this paper
• Tumour necrosis factor alpha-induced neuronal loss is mediated by microglial phagocytosis

  2014cited by this paper
• Results of phase II levetiracetam trial following acute head injury in children at risk for posttraumatic epilepsy

  2013influential reference
• Pentylentetrazole-induced loss of blood-brain barrier integrity involves excess nitric oxide generation by neuronal nitric oxide synthase.

  2013cited by this paper
• Levetiracetam has an activity‐dependent effect on inhibitory transmission

  2012cited by this paper
• Finding a better drug for epilepsy: The mTOR pathway as an antiepileptogenic target

  2012cited by this paper
• Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2

  2012cited by this paper
• Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates

  2012influential reference
• Why and how to target angiogenesis in focal epilepsies

  2012cited by this paper
• Results of phase 2 safety and feasibility study of treatment with levetiracetam for prevention of posttraumatic epilepsy.

  2012cited by this paper
• Mechanisms underlying blood–brain barrier dysfunction in brain pathology and epileptogenesis: Role of astroglia

  2012cited by this paper
• Physiology of microglia.

  2011cited by this paper
• Levetiracetam: a review of its use in epilepsy.

  2011cited by this paper
• The role of inflammation in epilepsy

  2011cited by this paper
• Microglial cell origin and phenotypes in health and disease

  2011cited by this paper
• Blood-arachnoid barrier disruption in experimental rat meningitis detected using gadolinium-enhancement ratio imaging.

  2011cited by this paper
• Status Epilepticus

  2011cited by this paper
• Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments

  2010cited by this paper
• Comprar A Clinical Guide to Epileptic Syndromes and their Treatment | Chrysostomos P. Panayiotopoulos | 9781849961608 | Springer

  2010cited by this paper
• Intravenous levetiracetam in the rat pilocarpine-induced status epilepticus model: behavioral, physiological and histological studies.

  2010cited by this paper
• Inflammatory Neurodegeneration and Mechanisms of Microglial Killing of Neurons

  2010cited by this paper
• Preventing and treating posttraumatic seizures: The human experience

  2009cited by this paper
• Astrocytes: biology and pathology

  2009cited by this paper
• Curing epilepsy: progress and future directions.

  2009cited by this paper
• From traumatic brain injury to posttraumatic epilepsy: What animal models tell us about the process and treatment options

  2009cited by this paper
• Epilepsy in later life.

  2009cited by this paper
• Levetiracetam inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture.

  2008cited by this paper
• Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study.

  2008cited by this paper
• Analyzing real-time PCR data by the comparative CT method

  2008cited by this paper
• Antiepileptogenesis Therapy with Levetiracetam: Data from Kindling versus Status Epilepticus Models

  2008cited by this paper
• Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy.

  2007cited by this paper
• Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats.

  2007cited by this paper
• Levetiracetam: Antiepileptic Properties and Protective Effects on Mitochondrial Dysfunction in Experimental Status Epilepticus

  2006cited by this paper
• Transcriptional regulation of the Vascular Endothelial Growth Factor gene--a concert of activating factors.

  2005cited by this paper
• Brain Inflammation in Epilepsy: Experimental and Clinical Evidence

  2005cited by this paper
• Treatment of Epilepsy: Focus on Levetiracetam

  2005cited by this paper
• Increased angiopoietin2 expression is associated with endothelial apoptosis and blood–brain barrier breakdown

  2005cited by this paper
• The Antiepileptic Drug Levetiracetam Decreases the Inositol 1,4,5-Trisphosphate-Dependent [Ca2+]i Increase Induced by ATP and Bradykinin in PC12 Cells

  2005cited by this paper
• Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus.

  2004cited by this paper
• The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.

  2004cited by this paper
• A CLINICAL GUIDE TO EPILEPTIC SYNDROMES AND THEIR TREATMENT

  2003cited by this paper
• Risk Factors for Posttraumatic Seizures in Adults

  2003cited by this paper
• Effects of lamotrigine and levetiracetam on seizure development in a rat amygdala kindling model.

  2003cited by this paper
• Selective Blockade of N‐Type Calcium Channels by Levetiracetam

  2002cited by this paper
• Effects of the Novel Antiepileptic Drug Levetiracetam on Spontaneous Recurrent Seizures in the Rat Pilocarpine Model of Temporal Lobe Epilepsy

  2002cited by this paper
• Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo

  2002cited by this paper
• The anti‐epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA‐ and glycine‐gated currents

  2002cited by this paper
• Epilepsy after brain insult: Targeting epileptogenesis

  2002cited by this paper
• Antiepileptogenesis and Seizure Prevention Trials with Antiepileptic Drugs: Meta‐Analysis of Controlled Trials

  2001cited by this paper
• Antiepileptic Drug Pharmacokinetics and Interactions: Impact on Treatment of Epilepsy

  2000cited by this paper
• Pharmacokinetic profile of levetiracetam: toward ideal characteristics.

  2000cited by this paper
• Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke

  2000cited by this paper
• Risk of unprovoked seizure after acute symptomatic seizure: Effect of status epilepticus

  1998cited by this paper
• Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy.

  1998cited by this paper
• Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.

  1997cited by this paper
• The Pilocarpine Model of Epilepsy in Mice

  1996cited by this paper
• Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps.

  1996cited by this paper
• The pilocarpine model of epilepsy

  1995cited by this paper
• Stereotaxic amygdalotomy for behavior disorders.

  1963cited by this paper

• Marked differences in the effects of levetiracetam and its analogue brivaracetam on microglial, astrocytic, and neuronal density in the rat model of kainic acid-induced temporal lobe epilepsy

  2025cites this paper
• The Role of Blood–Brain Barrier Disruption in Epilepsy: Mechanisms and Consequences

  2025cites this paper
• Effects of tramadol and levetiracetam in preventing peridural fibrosis after laminectomy in rats.

  2025cites this paper
• SUR1‐TRPM4 Regulates Aquaporin‐4 Subcellular Localization by Astrocytic Endfeet Calcium Signals Following Status Epilepticus

  2025cites this paper
• Innate immune activation and neuroinflammatory pathways in Epilepsy.

  2025cites this paper
• Exogenous Ketone Supplementation Enhances the Anti-Epileptic Effect of Levetiracetam in Wistar Albino Glaxo/Rijswijk Rats

  2025cites this paper
• Decreases in the number of microglia and neural circuit dysfunction elicited by developmental exposure to neonicotinoid pesticides in mice

  2024cites this paper
• Evaluation of Neuroinflammatory Contribution to Neurodegeneration in LRRK2 Drosophila Models

  2024cites this paper
• NLRP3 Inflammasome Inhibitors for Antiepileptogenic Drug Discovery and Development

  2024cites this paper
• Changes in the Dentate Gyrus Gene Expression Profile Induced by Levetiracetam Treatment in Rats with Mesial Temporal Lobe Epilepsy

  2024cites this paper
• Altered serum levels of platelet-derived growth factor receptor β and cluster of differentiation 13 suggest a role for pericytes in West syndrome.

  2023cites this paper
• Neuroinflammation and status epilepticus: a narrative review unraveling a complex interplay

  2023cites this paper
• The Primary Prevention of Poststroke Epilepsy in Patients With Middle Cerebral Artery Infarct: Protocol for a Randomized Controlled Trial

  2023cites this paper
• Antiseizure medication ≤48 hours portends better prognosis in new‐onset epilepsy

  2023cites this paper
• Suppressive Effects of Docosahexaenoic Acid Intake on Increased Seizure Susceptibility after Growth Due to Febrile Seizures in Infancy.

  2023cites this paper
• Impact of levetiracetam on cognitive impairment, neuroinflammation, oxidative stress, and neuronal apoptosis caused by lipopolysaccharides in rats

  2023cites this paper
• Early preclinical plasma protein biomarkers of brain trauma are influenced by early seizures and levetiracetam

  2023cites this paper
• Levetiracetam Mechanisms of Action: From Molecules to Systems

  2022cites this paper
• Beneficial effects of levetiracetam in streptozotocin-induced rat model of Alzheimer’s disease

  2022cites this paper
• Effects of Levetiracetam on the Serum C-Reactive Protein in Children With Epilepsy: A Meta-Analysis

  2022cites this paper
• Regulation of Inflammation-Related Genes through Fosl1 Suppression in a Levetiracetam-Treated Pilocarpine-Induced Status Epilepticus Mouse Model

  2022cites this paper
• Levetiracetam Suppresses the Infiltration of Neutrophils and Monocytes and Downregulates Many Inflammatory Cytokines during Epileptogenesis in Pilocarpine-Induced Status Epilepticus Mice

  2022cites this paper
• A CCR5 antagonist, maraviroc, alleviates neural circuit dysfunction and behavioral disorders induced by prenatal valproate exposure

  2022cites this paper
• Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats

  2021cites this paper
• FosL1 Is a Novel Target of Levetiracetam for Suppressing the Microglial Inflammatory Reaction

  2021cites this paper
• Pharmacological Investigations in Glia Culture Model of Inflammation

  2021cites this paper
• Effect of levetiracetam in combination with topiramate on immune function, cognitive function, and neuronal nutritional status of children with intractable epilepsy.

  2021cites this paper
• Therapeutic Effects of Time-Limited Treatment with Brivaracetam on Posttraumatic Epilepsy after Fluid Percussion Injury in the Rat

  2021cites this paper
• Preparation of single cell suspensions enriched in mouse brain vascular cells for single-cell RNA sequencing

  2021cites this paper
• Improvement in recurrent anti-myelin oligodendrocyte glycoprotein antibody - positive cerebral cortical encephalitis not requiring anti - inflammatory therapy following the decrease in cytokine/chemokine levels.

  2020cites this paper
• Comparison of the safety of brivaracetam at various doses among patients with epilepsy: A network meta-analysis of randomized controlled trials.

  2020cites this paper
• Microglial contributions to aberrant neurogenesis and pathophysiology of epilepsy

  2020cites this paper
• Repairing blood-CNS barriers: Future therapeutic approaches for neuropsychiatric disorders.

  2020cites this paper
• Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?

  2020cites this paper
• Protective Role of Levetiracetam Against Cognitive Impairment And Brain White Matter Damage in Mouse prolonged Cerebral Hypoperfusion.

  2019cites this paper
• Neuroprotective activation of astrocytes by methylmercury exposure in the inferior colliculus

  2019cites this paper
• Suppressive effects of levetiracetam on neuroinflammation and phagocytic microglia: a comparative study of levetiracetam, valproate and carbamazepine.

  2019cites this paper
• Changes in the Blood-Brain Barrier Function Are Associated With Hippocampal Neuron Death in a Kainic Acid Mouse Model of Epilepsy

  2018influential citation
• Antagonist targeting microRNA-146a protects against lithium-pilocarpine-induced status epilepticus in rats by nuclear factor-κB pathway.

  2018cites this paper
• Blood–Brain Barrier Leakage during Early Epileptogenesis Is Associated with Rapid Remodeling of the Neurovascular Unit

  2018cites this paper
• Neuroprotective effects of levetiracetam, both alone and combined with propylparaben, in the long‐term consequences induced by lithium‐pilocarpine status epilepticus

  2018cites this paper
• How Critical Illness Affects the Brain…and Vice Versa.

  2018cites this paper
• Potentiation of 17β-estradiol synthesis in the brain and elongation of seizure latency through dietary supplementation with docosahexaenoic acid

  2017cites this paper